Anticholesterol rosuvastatin not associated with reduced risk for fractures
Tuesday, December 2, 2014 - 07:30
in Health & Medicine
Treatment with the anticholesterol medicine rosuvastatin calcium did not reduce the risk of fracture among men and women who had elevated levels of an inflammatory biomarker, according to a report. "Our study does not support the use of statins in doses used for cardiovascular disease prevention to reduce the risk of fracture," the study concludes.